186 related articles for article (PubMed ID: 9408978)
1. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation.
Danielsson BR; Azarbayjani F; Sköld AC; Webster WS
Teratology; 1997 Oct; 56(4):271-81. PubMed ID: 9408978
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs?
Azarbayjani F; Danielsson BR
Teratology; 1998 Mar; 57(3):117-26. PubMed ID: 9587965
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.
Danielsson B; Sköld AC; Azarbayjani F; Ohman I; Webster W
Toxicol Appl Pharmacol; 2000 Mar; 163(2):164-75. PubMed ID: 10698674
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.
Azarbayjani F; Danielsson BR
Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972
[TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility to phenytoin teratogenicity: excessive generation of reactive oxygen species or impaired antioxidant defense?
Azarbayjani F; Borg LA; Danielsson BR
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):305-11. PubMed ID: 17040216
[TBL] [Abstract][Full Text] [Related]
6. The effect of drugs with ion channel-blocking activity on the early embryonic rat heart.
Abela D; Ritchie H; Ababneh D; Gavin C; Nilsson MF; Khan MK; Carlsson K; Webster WS
Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):429-40. PubMed ID: 20973055
[TBL] [Abstract][Full Text] [Related]
7. Effects of macrolide antibiotics on rat embryonic heart function in vitro.
Nilsson MF; Webster WS
Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):189-98. PubMed ID: 24753334
[TBL] [Abstract][Full Text] [Related]
8. The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.
Ritchie HE; Ababneh DH; Oakes DJ; Power CA; Webster WS
Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):144-53. PubMed ID: 23504928
[TBL] [Abstract][Full Text] [Related]
9. Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity.
Danielsson C; Azarbayjani F; Sköld AC; Sjögren N; Danielsson BR
Birth Defects Res A Clin Mol Teratol; 2007 Aug; 79(8):595-603. PubMed ID: 17584909
[TBL] [Abstract][Full Text] [Related]
10. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
11. Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.
Danielsson BR; Danielsson C; Nilsson MF
Reprod Toxicol; 2007 Jul; 24(1):42-56. PubMed ID: 17570632
[TBL] [Abstract][Full Text] [Related]
12. Phenytoin teratogenicity: hypoxia marker and effects on embryonic heart rhythm suggest an hERG-related mechanism.
Danielsson BR; Johansson A; Danielsson C; Azarbayjani F; Blomgren B; Sköld AC
Birth Defects Res A Clin Mol Teratol; 2005 Mar; 73(3):146-53. PubMed ID: 15744730
[TBL] [Abstract][Full Text] [Related]
13. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.
Danielsson BR; Skold AC; Azarbayjani F
Curr Pharm Des; 2001 Jun; 7(9):787-802. PubMed ID: 11375779
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Winn LM; Wells PG
Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
[TBL] [Abstract][Full Text] [Related]
15. A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media.
Ritchie HE; Svensson CH; Nilsson MF; Webster WS
J Pharmacol Toxicol Methods; 2014; 70(3):276-82. PubMed ID: 25091319
[TBL] [Abstract][Full Text] [Related]
16. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit.
Ozolins TR; Wiley MJ; Wells PG
Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862
[TBL] [Abstract][Full Text] [Related]
17. The effect of phenytoin on embryonic heart rate in Vivo.
Ritchie HE; Abela D; Ababneh D; Howe AM; Farrell E; Hegedus E
Reprod Toxicol; 2021 Dec; 106():109-114. PubMed ID: 34653594
[TBL] [Abstract][Full Text] [Related]
18. Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.
Danielsson BR; Sköld AC; Johansson A; Dillner B; Blomgren B
Toxicol Appl Pharmacol; 2003 Dec; 193(2):168-76. PubMed ID: 14644619
[TBL] [Abstract][Full Text] [Related]
19. Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos, in vitro.
Spence SG; Vetter C; Hoe CM
Teratology; 1994 Apr; 49(4):282-92. PubMed ID: 8073367
[TBL] [Abstract][Full Text] [Related]
20. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Winn LM; Wells PG
Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
